Latest Insider Transactions at Phase Bio Pharmaceuticals Inc (PHAS)
This section provides a real-time view of insider transactions for Phase Bio Pharmaceuticals Inc (PHAS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PhaseBio Pharmaceuticals Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PhaseBio Pharmaceuticals Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2020
|
Clay Thorp Director |
SELL
Other acquisition or disposition
|
Indirect |
52,397
-100.0%
|
-
|
|
Oct 01
2020
|
Susan Elizabeth Arnold SVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,423
+29.2%
|
$5,423
$1.15 P/Share
|
|
Feb 27
2020
|
Susan Elizabeth Arnold SVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,423
+41.23%
|
$5,423
$1.15 P/Share
|
|
Oct 22
2018
|
Astrazeneca PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
600,000
+16.65%
|
$3,000,000
$5.0 P/Share
|
|
Oct 22
2018
|
Astrazeneca PLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,404,554
+50.0%
|
-
|